Figure 2 | Hypertension Research

Figure 2

From: Prevention of metabolic disorders with telmisartan and indapamide in a Chinese population with high-normal blood pressure

Figure 2

Characteristics of the subjects during the 3-year follow-up period. *P<0.05 vs. placebo group, †P<0.05 vs. telmisartan group. This figure represents the repeated-measures analysis of variance (ANOVA) comparing the mean values of systolic blood pressure (SBP) (a), diastolic blood pressure (DBP) (b), waist circumference (WC) (c), triglycerides (TG) (d), high-density lipoprotein cholesterol (HDL-C) (e), low-density lipoprotein cholesterol (LDL-C) (f) and fasting plasma glucose (FPG) (g) among the groups, and the within-group comparisons among the three drugs. A full color version of this figure is available at Hypertension Research Journal online.

Back to article page